Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.
BACKGROUND & Globally, 350 million people are at risk for HCC. In this prospective multicenter study, a multi-target HCC blood test demonstrated substantially higher sensitivity for early-stage HCC detection than ultrasound while maintaining favorable screening performance across diverse patient subgroups.
BACKGROUND & Globally, 350 million people are at risk for HCC. In this prospective multicenter study, a multi-target HCC blood test demonstrated substantially higher sensitivity for early-stage HCC detection than ultrasound while maintaining favorable screening performance across diverse patient subgroups.
What the study was
- Study design
- Cross-sectional study
- Population
- Ultrasound screening is recommended but is limited by poor early-stage sensitivity and low adherence.
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Journal of hepatology
Why it surfaced
Cross-sectional study with abstract evidence; scored conservatively for novelty, clinical relevance, design quality, and population or unmet need.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.